Effects of Isthmus Preservation on Postoperative Hypothyroidism after Lobectomy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Many patients experience hypothyroidism after lobectomy. The purpose of this study was to investigate the effects of the extent of surgery (isthmus-saving lobectomy vs. isthmus-removing lobectomy) on postoperative hypothyroidism after lobectomy. Materials and Methods: In total, 144 consecutive benign or low-risk papillary thyroid cancer patients with euthyroid status were retrospectively enrolled from January 2016 to June 2018; 100 patients underwent isthmus-saving lobectomy (IS group), and 44 patients underwent isthmus-removing lobectomy (IR group). Thyroid function tests (TSH) were performed at 3, 6, 12, and 24 months after surgery. Levothyroxine was administered to patients with overt hypothyroidism and those with subclinical hypothyroidism who complained of obvious symptoms of hypothyroidism. Results: The TSH level was significantly lower in the IS group at 3 and 6 months after surgery (p=0.049 and 0.026, respectively). Among patients with TSH ＜2 μIU/mL preoperatively, 17 patients (17/66=25.8%) in the IS group had significantly maintained TSH levels at ＜2 μIU/mL compared with 2 patients (2/21=9.5%) in the IR group even after surgery (p=0.039). Postoperative overt hypothyroidism was found in 5 patients (5.0%) in the IS group and 6 patients (13.6%) in the IR group (p=0.048), and the numbers of patients who took medication after the surgery, 10 (10%) and 14 (31.8%), were significantly lower in the IS group (p=0.001). Conclusion: Isthmus-saving lobectomy in patients with euthyroid status reduced the incidence of postoperative hypothyroidism and thyroid hormone replacement and helped in maintaining a low TSH level when compared with isthmus-removing lobectomy.
Abstract
Background and Objectives: Many patients experience hypothyroidism after lobectomy. The purpose of this study was to investigate the effects of the extent of surgery (isthmus-saving lobectomy vs. isthmus-removing lobectomy) on postoperative hypothyroidism after lobectomy. Materials and Methods: In total, 144 consecutive benign or low-risk papillary thyroid cancer patients with euthyroid status were retrospectively enrolled from January 2016 to June 2018; 100 patients underwent isthmus-saving lobectomy (IS group), and 44 patients underwent isthmus-removing lobectomy (IR group). Thyroid function tests (TSH) were performed at 3, 6, 12, and 24 months after surgery. Levothyroxine was administered to patients with overt hypothyroidism and those with subclinical hypothyroidism who complained of obvious symptoms of hypothyroidism. Results: The TSH level was significantly lower in the IS group at 3 and 6 months after surgery (p=0.049 and 0.026, respectively). Among patients with TSH ＜2 μIU/mL preoperatively, 17 patients (17/66=25.8%) in the IS group had significantly maintained TSH levels at ＜2 μIU/mL compared with 2 patients (2/21=9.5%) in the IR group even after surgery (p=0.039). Postoperative overt hypothyroidism was found in 5 patients (5.0%) in the IS group and 6 patients (13.6%) in the IR group (p=0.048), and the numbers of patients who took medication after the surgery, 10 (10%) and 14 (31.8%), were significantly lower in the IS group (p=0.001). Conclusion: Isthmus-saving lobectomy in patients with euthyroid status reduced the incidence of postoperative hypothyroidism and thyroid hormone replacement and helped in maintaining a low TSH level when compared with isthmus-removing lobectomy.
참고문헌 (15)
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
- Stoll SJ, "Thyroid hormone replacement after thyroid lobectomy", Surgery, 146(4), pp.554~558 (2009)
- Wilson M, "Postoperative thyroid hormone supplementation rates following thyroid lobectomy", Am J Surg, 220(5), pp.1169~1173 (2020)
- Verloop H, "Risk of hypothyroidism following hemithyroidectomy : systematic review and meta-analysis of prognostic studies", J Clin Endocrinol Metab, 97(7), pp.2243~2255 (2012)
- Lee DY, "Prediction of thyroid hormone supplementation after thyroid lobectomy", J Surg Res, 193(1), pp.273~278 (2015)
- Shin HS, "Risk factors for hypothyroidism after thyroid lobectomy with papillary thyroid carcinoma according to existence of thyroiditis", Korean J Endocr Surg, 11(2), pp.90~96 (2011)
- 이명철, "Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer", Endocrinology and Metabolism, 34(2), pp.150~157 (2019), 대한내분비학회[DOI]
- Ahn D, "Hypothyroidism following hemithyroidectomy : incidence, risk factors, and clinical characteristics", J Clin Endocrinol Metab, 101(4), pp.1429~1436 (2016)
- Tian T, "Is TSH suppression still necessary in intermediate-and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin ＜1 ng", mL before the first disease assessment?, 2019, pp.65(1), 149~154
- Gharib H, "Thyroxine suppressive therapy in patients with nodular thyroid disease", Ann Intern Med, 128(5), pp.386~394 (1998)
- Biondi B, "Thyroid-hormone therapy and thyroid cancer : a reassessment", Nat Clin Pract Endocrinol Metab, 1(1), pp.32~40 (2005)
- McHenry CR, "Hypothyroidisim following hemithyroidectomy : incidence, risk factors, and management", Surgery, 128(6), pp.994~998 (2000)
- Miller FR, "Risk factors for the development of hypothyroidism after hemithyroidectomy", Arch Otolaryngol Head Neck Surg, 132(1), pp.36~38 (2006)
- Moon HG, "Thyrotropin level and thyroid volume for prediction of hypothyroidism following hemithyroidectomy in an Asian patient cohort", World J Surg, 32(11), pp.2503~2508 (2008)
- Park H, "Isthmusectomy in selected patients with well-differentiated thyroid carcinoma", Head Neck, 42(1), pp.43~49 (2020)